UBS Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19B | Buy |
|
|||||
|
2025
Q1 | $2.45B | Sell |
|
|||||
|
2024
Q4 | $2.24B | Buy |
|
|||||
|
2024
Q3 | $2.27B | Sell |
|
|||||
|
2024
Q2 | $2.04B | Buy |
|
|||||
|
2024
Q1 | $1.91B | Sell |
|
|||||
|
2023
Q4 | $1.69B | Buy |
|
|||||
|
2023
Q3 | $1.57B | Sell |
|
|||||
|
2023
Q2 | $1.5B | Buy |
|
|||||
|
2023
Q1 | $1.74B | Buy |
|
|||||
|
2022
Q4 | $1.75B | Buy |
|
|||||
|
2022
Q3 | $1.32B | Buy |
|
|||||
|
2022
Q2 | $1.49B | Buy |
|
|||||
|
2022
Q1 | $1.48B | Sell |
|
|||||
|
2021
Q4 | $1.32B | Buy |
|
|||||
|
2021
Q3 | $1.04B | Buy |
|
|||||
|
2021
Q2 | $1.09B | Buy |
|
|||||
|
2021
Q1 | $1,000M | Sell |
|
|||||
|
2020
Q4 | $1.02B | Buy |
|
|||||
|
2020
Q3 | $760M | Buy |
|
|||||
|
2020
Q2 | $766M | Buy |
|
|||||
|
2020
Q1 | $482M | Buy |
|
|||||
|
2019
Q4 | $492M | Buy |
|
|||||
|
2019
Q3 | $390M | Sell |
|
|||||
|
2019
Q2 | $436M | Sell |
|
|||||
|
2019
Q1 | $500M | Buy |
|
|||||
|
2018
Q4 | $534M | Sell |
|
|||||
|
2018
Q3 | $628M | Sell |
|
|||||
|
2018
Q2 | $671M | Buy |
|
|||||
|
2018
Q1 | $636M | Sell |
|
|||||
|
2017
Q4 | $764M | Sell |
|
|||||
|
2017
Q3 | $709M | Sell |
|
|||||
|
2017
Q2 | $611M | Buy |
|
|||||
|
2017
Q1 | $515M | Sell |
|
|||||
|
2016
Q4 | $498M | Sell |
|
|||||
|
2016
Q3 | $503M | Buy |
|
|||||
|
2016
Q2 | $487M | Buy |
|
|||||
|
2016
Q1 | $442M | Buy |
|
|||||
|
2015
Q4 | $427M | Buy |
|
|||||
|
2015
Q3 | $388M | Buy |
|
|||||
|
2015
Q2 | $468M | Buy |
|
|||||
|
2015
Q1 | $386M | Buy |
|
|||||
|
2014
Q4 | $325M | Buy |
|